Frontlight ResearchEarly access
Trial site
Klinikum rechts der Isar der Technischen Universität München
- 9running trials
- 5closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Pancreatic cancer3 trials
- Childhood cancers2 trials
- Liver and biliary tract cancer2 trials
- Prostate cancer2 trials
- Stroke2 trials
- ALS (motor neurone disease)1 trial
- Atrial fibrillation1 trial
- Gastric and oesophageal cancer1 trial
- Macular degeneration1 trial
- Melanoma1 trial
- Neuroblastoma1 trial
- Sarcoma1 trial
- Phase
- Phase 38 trials
- Phase 24 trials
- Phase 2/31 trial
- Status
- Completed5 trials
- Active, not recruiting3 trials
- Not yet recruiting3 trials
- Recruiting3 trials
- Suspended1 trial
- Lead sponsor
- AB Science1 trial
- Apellis Pharmaceuticals, Inc.1 trial
- BioNTech SE1 trial
- Biotronik SE & Co. KG1 trial
- Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1 trial
- and 10 more
Running trials
Not yet recruiting
Recruiting
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
Recruiting
Observation of Clinical Routine Care for Patients With BIOTRONIK Implantable Cardiac Monitors (ICMs)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers2 recruiting
- Pancreatic cancer2 recruiting
- Prostate cancer2 recruiting
- Neuroblastoma1 recruiting
- Sarcoma1 recruiting
Closed trials
Completed
Completed
Completed
Cabozantinib for Patients with Hepatocellular Carcinoma (HCC) Refractory to First Line Treatment
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026